This document discusses the development of a surgical simulation training system called ReSuture. It notes that surgical complications can be reduced by 50% with simulation training. ReSuture aims to provide a lifelike and cost-effective training platform for open vascular surgery using patent-pending lifelike materials and a pumping system to simulate blood flow. The startup is seeking $250k in funding to validate its first product, expand its advisory board, and market the simulation system to medical schools and hospitals to reduce errors and costs from avoidable complications in vascular surgery.

1. TRAININGTOMORROW’S SURGEONS
www.resuture.com

2. New surgeons are now
missing out on a year’s
worth of experience
Krafcik et al. J Vasc Surg. 2016

3. Impact
of avoidable vascular surgery
error results in patient
mortality
of vascular surgeries lead to
unplanned hospital
readmission
42% 15%
5X increase in cost to patients
& 119% increase in costs to
hospital
Healey et al. Arch Surg. 2002
Vonlathen et al. Annals of Surg.

4. Surgical complications can
be reduced by 50% with
simulation training
The Good News
Reed et al., Surgery, 2009

5. What We Do
The most realistic training platform for open vascular surgery
Lifelike
Individual practice Cost-effective

6. Lifelike, patent-
pending materials
The ReSuture
Training System

7. Pumping system to
simulate human
blood flow
Compact for
personal use

8. Market Size
$360M
Surgical
Simulation
$2.6B
Medical Simulation
Medical Simulation Centers
• Medical Schools
• Hospitals
• Research
• Military
Market growing at 16% CAGR
“Healthcare/Medical Simulation Market.” Markets and Markets, 2018

9. Competitive Landscape
Cadaver Lab Porcine Lab SynDaver
Realistic
experience
Includes
surrounding
anatomical
structures
Multiple uses in
same system
Low Cost

10. Completion of validated first product
Pilot programs with 2 medical schools in 2020
Introducing product at 2020 International Meeting
on Simulation in Healthcare
Traction

11. Razor & Blade Model
Vasculature
Simulated tissue
“Skin” pads
Medical Schools &
Hospitals
Consumables Revenue Streams
Simulation Systems

12. Product Timeline
Spring 2020
AnastomosisTrainer
Fall 2020
Femoral Endarterectomy
Abdominal Aortic Aneurysm
Spring 2021
Aortic Arch Repair
Coronary Artery Bypass
Spring 2021
Central Line Placement
Aortocaval Fistula Repair

13. A Team of Innovators
Hannah Eherenfeldt
CEO & Co-Founder
Benjamin Knapp
COO & Co-Founder
Drew Mouton
Strategy Director
Biomedical engineer with a passion
for design and prior experience
commercializing biotech at the New
Orleans Bioinnovation Center.
Previously developed simulations for
the Tulane Center for Advanced
Medical Simulation. Talented with 3D
printers and silicone casting.
Currently the Chief Innovation Officer
at LSU Health Sciences Center. Serial
entrepreneur and former CEO of
publicly traded company.

14. Go-to-market timeline
Spring 2019 Spring 2020
Pilot programs withTulane
and LSU
Fall 2020
Secure manufacturing partnership
Fall 2019
Provisional patent filed
Summer 2020
PublishedWhite Paper
Winter 2020
Market launch and begin
expansion into other surgical
disciplines
Field validation of first
product

15. The Ask
We are currently raising $250K
Needs:
• Connections with
vascular surgeons
• Connections with
ASU/Mayo and UA
Medical School, local
hospitals
• Building outAdvisory
Board
• Manufacturing products for validation
study
• Publishing White Paper
• Marketing
• New product development
• Staffing

16. Thisisawesome—I’veneverseenaproduct
like thisbefore.Thiswouldbegreatinour
surgical training programs.
Dr. Christopher DuCoin
Former Surgical Clerkship Director
Tulane School of Medicine
www.resuture.com
hannah@resuture.com
/company/resuture-llc
/resuture
@re_suture

17. 0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
3,000,000
3,500,000
4,000,000
4,500,000
2 institutions 5 institutions 15 institutions
3750 units
1250 units
200 units
(3 uses/unit)
Financial Projections
Consumables sales
revenue
Systems sales
revenue

18. ReSuture Carotid Endarterectomy Trainer